E2F7 and hepatocellular carcinoma: Taken together, our study confirmed that circLATS2 promotes the proliferation, migration, and invasion ability of HCC cells through miR-520a-3p/E2F7-VEGFR2 signaling pathway, which may be a potential target for HCC therapeutic.